Home > Blog Tag

Blog Posts by Tag: Data Quality - Insurance Discovery

Consider Closing Out the Year Strong With an Accounts Receivable (AR) Clean-up

Enjoy the following content from our partner, FrontRunnerHC. If you’re like most organizations, 2020 has impacted your patient volume and cash collection, so capturing every dollar of the revenue you’re entitled to is critical. Recently, I wrote an article featured in Beckers Hospital Review about three key reasons claims are piling up in your Accounts Receivable (AR) ledger. (To check out the...

Read


XIFIN RPM 12: Additional Appeals Automation Capabilities, Expanded Advanced Analytics and Patient Data Discovery, and More

Laboratory testing volume is at an all-time high. Molecular testing volume, for example, is currently at 275% of pre-COVID-19 levels. Diagnostic providers must transform their revenue cycle management (RCM) to adapt quickly to this changed world. This is not a challenge that can be overcome by throwing people at it. That is not a sustainable, scalable solution and during the COVID-19 pandemic is...

Read


Is Your Lab Embracing the ‘Consumerism in Healthcare’ Era? It Should.

Enjoy the following content from our partner, FrontRunnerHC. The concept of consumerism in healthcare has evolved over the years, and whether we are in support of it or not, we must trust that the industry landscape has a new driver: the patient. The patient is taking charge of their healthcare more than ever. As consumers, they are proactively researching the different service options available...

Read


The Impact of Surprise Bills - What's Your Lab Going to Do About It?

In the time of information accessibility, patients are still left in the dark when it comes to their insurance coverage, which leads to surprise medical bills flooding one out of five American mailboxes. This distress creates a negative ripple effect that not only disrupts their financial situation but also affects labs. How did this happen?According to Kaiser Family Foundation, 72% of health...

Read


XIFIN’s Data Assists in Discovery of Standards Violation

With more than 3,000 payors, a siloed provider will not have the breadth and depth of data to determine if payors are adhering to standards. Because of the high volume of claims XIFIN processes and the managed services that are offered as part of our XIFIN RPM solution, our EDI services team has visibility across these payors for all of our clients. As the provider of a cloud-based revenue...

Read


Accurate Patient Responsibility Estimates Dramatically Improve the Patient Experience

Customer experience is one of the most significant long-term differentiators in healthcare and diagnostics, as it is in virtually all other sectors. There is a direct correlation between customer experience and engagement, and consumers have been trained to expect more when it comes to service and experience by companies such as Amazon, Apple, and Southwest Airlines. A survey of 1,000 patients...

Read


Hidden Landmines in Revenue Cycle Management: Industry Challenges, Patient Engagement, and Denial Trends (Part 1)

This is the first post of a three-part blog series focused on key areas of business performance management for pathology practices, hospital outreach programs, diagnostic laboratories, and molecular diagnostic providers. The other blog posts in this series can be found here:  Part 2 and Part 3 A number of trends in payor behaviors and reimbursement...

Read


New Study Demonstrates GAO’s PAMA Report Based on Faulty Assumptions

In a XIFIN blog post from April 5, we address that the Government Accountability Office (GAO) report entitled, “Medicare Laboratory Tests Implementation of New Rates May Lead to Billions in Excess Payments” appears to demonstrate a misunderstanding of how price and panel bundling work in laboratory billing and reimbursement.The report appears to suggest that American Medical Association (AMA)...

Read